Multi-Centre, Parallel Group, Double-Blind, Placebo Controlled Study of the Efficacy and Tolerability of Tonabersat [Minster Pharmaceuticals] in the Prophylaxis of Migraine Headache

Trial Profile

Multi-Centre, Parallel Group, Double-Blind, Placebo Controlled Study of the Efficacy and Tolerability of Tonabersat [Minster Pharmaceuticals] in the Prophylaxis of Migraine Headache

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jun 2015

At a glance

  • Drugs Tonabersat (Primary)
  • Indications Migraine
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Minster Pharmaceuticals
  • Most Recent Events

    • 01 Jul 2009 Results were publshed in Cephalalgia.
    • 01 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top